本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Enliven Treateutics

55.30
+0.98001.80%
成交量:30.60萬
成交額:1,676.91萬
市值:40.52億
市盈率:-33.01
高:55.82
開:55.00
低:54.01
收:54.32
52周最高:62.32
52周最低:14.79
股本:7,327.08萬
流通股本:6,172.59萬
量比:0.55
換手率:0.50%
股息:- -
股息率:- -
每股收益(TTM):-1.6753
每股收益(LYR):-1.8300
淨資產收益率:-15.31%
總資產收益率:-11.00%
市淨率:4.53
市盈率(LYR):-30.22

資料載入中...

2026/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/22

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/12

重要事件披露

Form 8-K - Current report
2026/06/11

重要事件披露

Form 8-K - Current report
2026/06/10

重要事件披露

Form 8-K - Current report
2026/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]